Alpha 2.0
Login Register
» Authors » Fungai Musaigwa

Fungai Musaigwa

Explore the profile of Fungai Musaigwa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 63
Followers 0
Related Specialties
Allergy & Immunology
Oncology
Top 10 Co-Authors
Justin Komguep Nono
Frank Brombacher
Nada Abdel Aziz
Paballo Mosala
Thabo Mpotje
Severin Donald Kamdem
Raphael Taiwo Aruleba
DeBroski R Herbert
Olugbenga Samson Onile
Wenqin Luo
Published In
Front Immunol
Afr J Lab Med
PLoS Pathog
Vaccines (Basel)
Trends Parasitol
Affiliations
Soon will be listed here.
Recent Articles
1.
MrgprA3 neurons drive cutaneous immunity against helminths through selective control of myeloid-derived IL-33
Inclan-Rico J, Napuri C, Lin C, Hung L, Ferguson A, Liu X, et al.
Nat Immunol . 2024 Oct; 25(11):2068-2084. PMID: 39354200
Skin uses interdependent cellular networks for barrier integrity and host immunity, but most underlying mechanisms remain obscure. Herein, we demonstrate that the human parasitic helminth Schistosoma mansoni inhibited pruritus evoked...
2.
Cysteinyl leukotriene receptor-1 as a potential target for host-directed therapy during chronic schistosomiasis in murine model
Mosala P, Mpotje T, Abdel Aziz N, Ndlovu H, Musaigwa F, Nono J, et al.
Front Immunol . 2024 Jun; 15:1279043. PMID: 38840916
Schistosomiasis remains the most devastating neglected tropical disease, affecting over 240 million people world-wide. The disease is caused by the eggs laid by mature female worms that are trapped in...
3.
Harnessing Schistosoma-associated metabolite changes in the human host to identify biomarkers of infection and morbidity: Where are we and what should we do next?
Kameni M, Musaigwa F, Kamguia L, Kamdem S, Mbanya G, Lamberton P, et al.
PLoS Negl Trop Dis . 2024 Mar; 18(3):e0012009. PMID: 38512811
Schistosomiasis is the second most widespread parasitic disease affecting humans. A key component of today's infection control measures is the diagnosis and monitoring of infection, informing individual- and community-level treatment....
4.
Immunoinformatics Studies and Design of a Potential Multi-Epitope Peptide Vaccine to Combat the Fatal Visceral Leishmaniasis
Onile O, Musaigwa F, Ayawei N, Omoboyede V, Onile T, Oghenevovwero E, et al.
Vaccines (Basel) . 2022 Oct; 10(10). PMID: 36298463
Leishmaniasis is a neglected tropical disease caused by parasitic intracellular protozoa of the genus . The visceral form of this disease caused by continues to constitute a major public health...
5.
Type 2 immunity: a two-edged sword in schistosomiasis immunopathology
Abdel Aziz N, Musaigwa F, Mosala P, Berkiks I, Brombacher F
Trends Immunol . 2022 Jul; 43(8):657-673. PMID: 35835714
Schistosomiasis is the second most debilitating neglected tropical disease globally after malaria, with no available therapy to control disease-driven immunopathology. Although schistosomiasis induces a markedly heterogenous immune response, type 2...
6.
The Practicality of the Use of Liquid Biopsy in Early Diagnosis and Treatment Monitoring of Oral Cancer in Resource-Limited Settings
Adeola H, Bello I, Aruleba R, Francisco N, Adekiya T, Adefuye A, et al.
Cancers (Basel) . 2022 Mar; 14(5). PMID: 35267452
An important driving force for precision and individualized medicine is the provision of tailor-made care for patients on an individual basis, in accordance with best evidence practice. Liquid biopsy(LB) has...
7.
Schistosoma mansoni infection induces plasmablast and plasma cell death in the bone marrow and accelerates the decline of host vaccine responses
Musaigwa F, Kamdem S, Mpotje T, Mosala P, Abdel Aziz N, Herbert D, et al.
PLoS Pathog . 2022 Feb; 18(2):e1010327. PMID: 35157732
Schistosomiasis is a potentially lethal parasitic disease that profoundly impacts systemic immune function in chronically infected hosts through mechanisms that remain unknown. Given the immunoregulatory dysregulation experienced in infected individuals,...
8.
Praziquantel Treatment of Infected Mice Renders Them Less Susceptible to Reinfection
Nono J, Mpotje T, Mosala P, Abdel Aziz N, Musaigwa F, Hlaka L, et al.
Front Immunol . 2021 Dec; 12:748387. PMID: 34956183
Beyond transient control of the infection, additional benefits of mass drug administration of praziquantel in endemic communities have been suggested in communities but not mechanistically investigated experimentally. The present study...
9.
Influence of schistosomiasis on host vaccine responses
Nono J, Kamdem S, Musaigwa F, Nnaji C, Brombacher F
Trends Parasitol . 2021 Aug; 38(1):67-79. PMID: 34389214
Schistosomiasis is a debilitating helminthiasis which commonly establishes as a chronic infection in people from endemic areas. As a potent modulator of the host immune response, the Schistosoma parasite and...
10.
In-depth investigation of turn-around time of full blood count tests requested from a clinical haematology outpatient department in Cape Town, South Africa
Mutema L, Chapanduka Z, Musaigwa F, Mashigo N
Afr J Lab Med . 2021 May; 10(1):1318. PMID: 34007817
Background: The performance of laboratories can be objectively assessed using the overall turn-around time (TAT). However, TAT is defined differently by the laboratory and clinicians; therefore, it is important to...